BioNTech to buy Biotheus, gaining control of cancer bispecific

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit Therapeutics’ ivonescimab over Keytruda.

Nigeria launches second phase of climate action transparency initiative – EnviroNews

December 14, 2024

NDCs: Council engages stakeholders in carbon market regulation – EnviroNews

December 14, 2024

Source link

BioNTech to buy Biotheus, gaining control of cancer bispecific

Nigeria launches second phase of climate action transparency initiative – EnviroNews

NDCs: Council engages stakeholders in carbon market regulation – EnviroNews

Thales Partners Febus Optics for Undersea Infrastructure Surveillance

Kenya-US strategic partnership unfazed by Donald Trump’s win

Kenya-US strategic partnership unfazed by Donald Trump's win

Leave a Reply Cancel reply

RECOMMENDED NEWS

Post-Brady era: Buccaneers reduce seating at Raymond James Stadium

Ten Reasons Why Human Flourishing Has Reversed

Land Moto accelerates its electric bike battery play with $3M infusion

Defense One Radio, Ep. 154: Behind the rise in global defense spending, Part 3: The wider world

POPULAR NEWS

When Will SHIB Reach $1? Here’s What ChatGPT Says

Matthew Slater, son of Jackson State great, happy to see HBCUs back at the forefront

Dolly Varden Focuses on Adding Ounces the Remainder of 2023

US Dollar Might Fall To 96-97 Range in March 2024

Mass Casualty At Concerts: Vaccinated Crowds ‘Die Suddenly”

BioNTech to buy Biotheus, gaining control of cancer bispecific

Related posts

Thales Partners Febus Optics for Undersea Infrastructure Surveillance

Kenya-US strategic partnership unfazed by Donald Trump’s win

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS